respiratory
COPD

Blood eosinophils a promising biomarker in COPD


Blood eosinophils are a promising biomarker to predict the therapeutic response to inhaled corticosteroids in patients with COPD, research suggests. The post- hoc analysis of data from two double-blind, randomised placebo-controlled trials compared fixed combination of inhaled corticosteroids (fluticasone furoate at three doses, 50, 100, and 200 μg) and a long-acting β-agonist (vilanterol at 25 μg) ...

Already a member?

Enter your email to keep reading.


OR